(5,6-DIHYDRO-8H-IMIDAZO[2,1-C][1,4]OXAZIN-6-YL)METHANOL, 95.0%, 1g

tert-butyl N-{[(2R,4S)-4-fluoropyrrolidin-2-yl]methyl}carbamate hydrochloride, 95.0%, 1g

(4-Aminopyrimidin-5-yl)methanol, 95+%, 250mg

2-Fluoro-3-methoxybenzoic Acid>98.0%(GC)(T)5g

(E)-1-(2-Nitrovinyl)-3-(trifluoromethyl)benzene, 95.0%, 5g

(4R,4'R)-2,2'-(1-Phenylpropane-2,2-diyl)bis(4-phenyl-4,5-dihydrooxazole), 97%, 250mg

(S)-1-(2-Chloroacetyl)-pyrrolidine-2-carbonitrile, 95.0%, 10g

(S)-2-amino-3-(2-fluoro-4-hydroxyphenyl)propanoic acid, 98%, 500mg

(Z)-4,4,5,5-Tetramethyl-2-(prop-1-en-1-yl)-1,3,2-dioxaborolane, 95% mix TBC as stabilizer, 5g

(S)-2-(1-Aminopropyl)-5-fluoro-3-phenylquinazolin-4(3H)-one, 95.0%, 5g

7-bromo-3H,4H-pyrido[3,4-d]pyridazin-4-one, 95%, 250mg

N-ethyl-2-(4-methyl-1-piperazinyl)ethanamine trihydrochloride, 95.0%, 5g

N-CYCLOPROPYLOXETAN-3-AMINE, 95.0%, 5g